Steel N.Dehydro-epiandrosterone and ageing. Bonemorphogenetic protein regulate the developmental program of humanhematopoietic stem cells. Expanding role ofbiphosphonate therapy in children. Genetic regulationof estrogen responsiveness. Recent progress in understanding the genetic susceptibility toosteoporosis. Biochemical markers of bone turnover and prediction of hipbone loss in older women: the study of osteoporotic fractures. Levine MA.Pseudohypoparathyroidism: from bedside to bench and back. On the estrogen-bonerelationship and postmenopausal bone loss: a new model. Natural history of growth hormone receptordeficiency. Rosenbloom AL, MartínezV, Kranzier JH, et al. Hofbauer LC, Khosla S.Androgens effects on bone metabolism: recent progress andcontroversies. Non-invasive assessment of bone density in primary biliarycirrhosis. Thenonsurgical treatment of fibrous dysplasia. Rickets today Children still need milk and sunshine. Polycystic bone disease: a new autosomal dominantdisorder. Whyte MP, Eddy MC, PodgornikMN, McAlister WH. A metaanalysis on the use of biphosphonates incorticosteroid induced osteoporosis. Androgeneffects on bone metabolism: recent progress and controversies. Recent advances in bone biology provide insight into thepathogenesis of bone diseases. Clin Endocrinol (Oxf) 1999 50: 411-414.īoyce BF, Hughes DE, Wrigh KR,et al. The effects oftestosterone on osteoporosis in men. Questionnaire survey ofadvice given to patients with fractures. Rae SA, Wang WJ, Partridge D.Artificial neural networks: a potential role in osteoporosis. Calcimimeticcompounds: a direct approach to controlling plasma levels ofparathyroid hormone in hyperparathyroidism. Selectiveestrogen receptor modulators: clinical spectrum. Trends Endocrinol Metab1999 10: 61-65.Ĭosman F, Lindsay R. Control ofbone growth by fibroblast growth factors. The actions and interactions of sex steroids and growthfactors/cytokines on the skeleton. Evidence-basedmanagement of patients with osteoporosis. Vitamin D3derivatives (deltanoids) in the treatment of tumor cell invasion.
Roshan S, Nader S, Orander P.Ageing and hormones. Se ruega a los autoresenviar una copia del trabajo para incluir su cita en estasección. Determination of vitamin D3 metabolites:state-of-the-art and trends. Osteoporosis Int 1999 9: 441-448.Ĭastro MDL, FernándezRomero JM, Ortiz Boyer B.
Changes in bone density after exposure to oral anticoagulants:A meta analysis. Rev Clin Esp 1999 199: 523-529.Ĭarballo PJ, Gabriel SE, CastroMR. Relaciones hipertensión arterialesencial-osteoporosis: impacto del tratamiento antihipertensivosobre el metabolismo extracelular del calcio. Polimorfismo del gen del receptor de la vitamina D ydensitometría ósea en mujerespostmenopáusicas. Madrid: Idepsa,1999.īernard M, Jaramillo G, AguadoP, et al. Luque M, Rapado A, eds.Hipertensión y osteoporosis. Manuscritos del 9th EuropeanMeeting on Injectable Bone and Joint Substitution Materials. Kozlowski K, Beighton P, eds.Gamut index of skeletal dysplasias: an aid to radiodiagnosis(3. Rosenfeld RG, Roberts C, eds.The IGF system: Molecular biology, physiology and clinicalapplications. Estrogens and progestagens in clinical practice.New York: Churchill Livingstone, 1999. Totowa: Humana Press,1999.įraser IS, Jansen PSR, Lobo RA,Whitehead MI, eds. Seifer DB, Kennard EA, ed.Menopause: Endocrinology and management.
0 kommentar(er)
